Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05897788 · ClinicalTrials.gov registry record · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
A NA study of Opioid Use Disorder and Opioid Dependence With Current Use (Disorder), sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 1,808
- Enrollment target
- 1
- Study location
NCT05897788 is a NA study of Opioid Use Disorder and Opioid Dependence With Current Use (Disorder) that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,808 participants, below the 4,649-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05897788, a NA study of Opioid Use Disorder and Opioid Dependence With Current Use (Disorder), is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,808 participants
- Enrollment target
- 1
- Study location
Study Summary
There is growing recognition of the need for approaches to initiate treatment wherever patients touch the health care system, including the Emergency Department (ED). Most research has focused on initiation of medications for opioid use disorder (MOUDs) in the ED rather than ensuring continued treatment post-discharge. The investigators propose to adapt evidence-based interventions to support patients' complex needs and facilitate continued treatment, rather than discharging them and having them navigate outpatient treatment systems with limited support. The research team will randomize participants into 1 of 4 arms to receive varying degrees of augmented usual care, including daily check-ins and contingency management. The investigators plan to examine the effects of check-ins and contingency management on engagement with addiction treatment and equity of treatment effects among racial and ethnic subgroups and assess important moderators of treatment effects.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
- BEHAVIORAL Text Message Check-ins
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,808 participants |
| Start Date | 2024-03-20 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05897788
The ClinicalTrials.gov registry entry for NCT05897788 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,808 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,649-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (61% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Contingency Management is the first listed.
NCT05897788 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05897788 about?
NCT05897788 is a clinical study titled "Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement". There is growing recognition of the need for approaches to initiate treatment wherever patients touch the health care system, including the Emergency Department (ED). Most research has focused on initiation of medications for opioid use disorder (MOUDs) in the ED rather than ensuring continued treat...
What is the current status of trial NCT05897788?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,808 participants. The study started on 2024-03-20. Estimated completion is 2026-11-30.
What conditions does trial NCT05897788 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Dependence With Current Use (Disorder).
What interventions are being tested in trial NCT05897788?
The interventions under investigation include: Contingency Management (BEHAVIORAL), Text Message Check-ins (BEHAVIORAL).
Who is sponsoring clinical trial NCT05897788?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05897788 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Explore more on PlainTrial
Opioid Use Disorder
All registered trials for this condition
Opioid Dependence With Current Use (Disorder)
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.